ClinicalTrials.Veeva

Menu

The Prediction of Preeclampsia/Toxemia in Twin Pregnancy

S

Shamir Medical Center (Assaf-Harofeh)

Status

Unknown

Conditions

Preeclampsia/Toxemia

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to finout whetere uterinae artery flow , PP13 and endogolin levels in the serum and kongo red in the urine can predict preeclamsia toxemia in twin pregnancies.

Enrollment

200 estimated patients

Sex

Female

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • a women with a vaiable twin pregnany

Exclusion criteria

  • women with thrombophilya
  • women terated with anticoagolant
  • women with vascular disease

Trial design

200 participants in 1 patient group

twin preganacies

Trial contacts and locations

1

Loading...

Central trial contact

Ran Svirsky, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems